Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case

Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case

Source: 
Endpoints
snippet: 

Amgen will soon be the 10th biopharma company to pull back on offering drug discounts to contract pharmacies of safety-net hospitals under a federal program. Like its peers, Amgen argues that the growth of these contract pharmacies has ballooned in recent years and needs to be reigned in.